Abstract

SummarySulfamerazine has no effect on any of the endotoxins of the agents of the lymphogranuloma-psittacosis group and on the early deaths produced by such toxins, even when these are used in doses on the border line of lethality and are derived from lymphogranuloma venereum or mouse pneumonitis both of which infections are very susceptible to sulfonamide therapy. On the other h and, of the later deaths which occur following intravenous inoculation of the agents of mouse or feline pneumonitis, those occurring with mouse pneumonitis are entirely prevented with sulfamerazine while those with feline pneumonitis are not. These facts are in keeping with the previously postulated theory that these later deaths are due to infection while the earlier are due to toxemia.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.